Optics, Machine Vision Algorithms at Heart of Epic-USC Collaboration - IDEX Health & ScienceIDEX Health & Science


    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Optics, Machine Vision Algorithms at Heart of Epic-USC Collaboration

    Article obtained from Photonics RSS Feed.

    Epic Sciences Inc., a diagnostics and disease profiling company, announced it has entered into an exclusive license and collaboration agreement with the University of Southern California (USC) Michelson Center for Convergent Bioscience, and the center’s Dr. Peter Kuhn, who leads USC’s Convergent Science Institute in Cancer (CSI-Cancer). The collaboration enhances the ability to provide precision characterizations of rare circulating tumor cells (CTCs). Epic is currently developing CTCs into liquid biopsy diagnostics for characterizing cancers to better guide treatment decisions.

    Epic’s platform uses precision optics paired with AI-trained machine vision algorithms to analyze fluorescent antibodies-treated blood….

    Nov, 23 2020 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.